Da EU-erhvervsgrenen ikke kunne foretage supplerende investeringer for celler og wafere i den betragtede periode, var investeringsniveauet i UP forholdsvis lavt.
Since the Union industry could not afford making additional investments for cells and wafers during the period considered, the level of investments during the IP was rather low.